1. New insights in the molecular pathogenesis of Epstein–Barr virus-positive and -negative post-transplant diffuse large B-cell lymphoma. (July 2016) Authors: Morscio, J.; Ferreiro, J. Finalet; Dierickx, D.; Verhoef, G.; Wlodarska, I.; Tousseyn, T. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Myeloid-derived suppressor cells in lymphoma: The good, the bad and the ugly. Issue 6 (November 2018) Authors: Betsch, A.; Rutgeerts, O.; Fevery, S.; Sprangers, B.; Verhoef, G.; Dierickx, D.; Beckers, M. Journal: Blood reviews Issue: Volume 32:Issue 6(2018:Nov.) Page Start: 490 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Gene Expression Profiling Reveals Clear Differences Between EBV‐Positive and EBV‐Negative Posttransplant Lymphoproliferative Disorders. Issue 5 (14th March 2013) Authors: Morscio, J.; Dierickx, D.; Ferreiro, J. F.; Herreman, A.; Van Loo, P.; Bittoun, E.; Verhoef, G.; Matthys, P.; Cools, J.; Wlodarska, I.; De Wolf‐Peeters, C.; Sagaert, X.; Tousseyn, T. Journal: American journal of transplantation Issue: Volume 13:Issue 5(2013:May) Page Start: 1305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A FIRST‐IN‐HUMAN STUDY OF A HALF‐LIFE EXTENDED CD19‐TARGETING BiTE IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA, MANTLE CELL LYMPHOMA OR FOLLICULAR LYMPHOMA. (12th June 2019) Authors: Popplewell, L.; Verhoef, G.; Kuruvilla, J.; Tuglus, C.; Kischel, R.; Stieglmaier, J.; Ghobadi, A. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 566 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PHASE 2 STUDY OF PARSACLISIB (INCB050465) FOR RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) (CITADEL‐202). (12th June 2019) Authors: Belada, D.; Fay, K.; Casasnovas, R.; Gressin, R.; Lee, H.; Mehta, A.; Munoz, J.; Verhoef, G.; Corrado, C.; DeMarini, D.; Zhao, W.; Chen, X.; Coleman, M. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 326 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. RITUXIMAB MAINTENANCE FOR PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA IN FIRST COMPLETE REMISSION: RESULTS FROM A RANDOMIZED HOVON‐NORDIC LYMPHOMA GROUP PHASE III STUDY. (12th June 2019) Authors: Lugtenburg, P.; de Nully Brown, P.; van der Holt, B.; d'Amore, F.; Koene, H.; de Jongh, E.; Fijnheer, R.; Loosveld, O.; Böhmer, L.; Pruijt, H.; Verhoef, G.; Hoogendoorn, M.; Bilgin, Y.; Nijland, M.; Lam, K.; de Keizer, B.; de Jong, D.; Zijlstra, J. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P1151: METABOLIC TUMOR VOLUME IMPROVES OUTCOME PREDICTION IN UNTREATED MANTLE CELL LYMPHOMA. (23rd June 2022) Authors: Vergote, V. K.; Verhoef, G.; Janssens, A.; Woei-a-jin, F. S.; Laenen, A.; Tousseyn, T.; Dierickx, D.; Deroose, C. M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1038 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. CHARACTERISTICS AND OUTCOME OF POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS AFTER SOLID ORGAN TRANSPLANTATION. (October 2022) Authors: Vergote, V.; Uyttebroeck, A.; Deroose, C.; Fieuws, S.; Laleman, W.; Sprangers, B.; Van Cleemput, J.; Verhoef, G.; Vos, R.; Tousseyn, T.; Dierickx, D. Journal: Leukemia research Issue: Volume 121(2022)Supplement Page Start: S26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. EBV‐Positive and EBV‐Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic Features. (18th January 2016) Authors: Finalet Ferreiro, J.; Morscio, J.; Dierickx, D.; Vandenberghe, P.; Gheysens, O.; Verhoef, G.; Zamani, M.; Tousseyn, T.; Wlodarska, I. Journal: American journal of transplantation Issue: Volume 16(2016)Supplement 2 Page Start: 414 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Treatment with lenalidomide (Revlimid®), cyclophosphamide (Endoxan®) and prednisone (REP) in relapsed/refractory multiple myeloma patients: results of a single centre retrospective study. Issue 2 (April 2014) Authors: Zelis, N.; Devos, T.; Dierickx, D.; Janssens, A.; Raddoux, J.; Verhoef, G.; Delforge, M. Journal: Acta clinica belgica Issue: Volume 69:Issue 2(2014) Page Start: 98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗